Methods are disclosed for inhibiting the differentiation of an activated T-cell into a cytotoxic lymphocyte in a mammalian subject, comprising administering to a subject a therapeutically effective amount of a PSGL antagonist. ...http://www.google.ca/patents/US20020058034?utm_source=gb-gplus-sharePatent US20020058034 - Inhibition of differentiation of cytotoxic T-cells by P-selectin ligand (PSGL) antagonists
